Literature DB >> 32355346

Composition of unapproved cannabinoid products directly marketed to Canadian pet owners.

Alan Chicoine1, Stephanie Vuong1, Kate Illing1, Jonathan Hare1, Jennifer Caldwell1, Ian Sandler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32355346      PMCID： PMC7155876     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: An explorative study.

Authors:  Beata Łebkowska-Wieruszewska; Fabio Stefanelli; Silvio Chericoni; Helen Owen; Amnart Poapolathep; Andrzej Lisowski; Mario Giorgi
Journal:  Res Vet Sci       Date:  2018-12-17       Impact factor: 2.534

2.  Canadian dog owners' use and perceptions of cannabis products.

Authors:  Lori R Kogan; Peter W Hellyer; Sarah Silcox; Regina Schoenfeld-Tacher
Journal:  Can Vet J       Date:  2019-07       Impact factor: 1.008

3.  Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.

Authors:  Gerald T DeLong; Carl E Wolf; Alphonse Poklis; Aron H Lichtman
Journal:  Drug Alcohol Depend       Date:  2010-11-01       Impact factor: 4.492

4.  Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.

Authors:  Lisa R Bartner; Stephanie McGrath; Sangeeta Rao; Linda K Hyatt; Luke A Wittenburg
Journal:  Can J Vet Res       Date:  2018-07       Impact factor: 1.310

Review 5.  Molecular Pharmacology of Phytocannabinoids.

Authors:  Sarah E Turner; Claire M Williams; Leslie Iversen; Benjamin J Whalley
Journal:  Prog Chem Org Nat Prod       Date:  2017

6.  Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy.

Authors:  Stephanie McGrath; Lisa R Bartner; Sangeeta Rao; Rebecca A Packer; Daniel L Gustafson
Journal:  J Am Vet Med Assoc       Date:  2019-06-01       Impact factor: 1.936

7.  Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study.

Authors:  Richard J Huntsman; Richard Tang-Wai; Jane Alcorn; Stephanie Vuong; Bryan Acton; Scott Corley; Robert Laprairie; Andrew W Lyon; Simona Meier; Darrell D Mousseau; Doris Newmeyer; Erin Prosser-Loose; Blair Seifert; Jose Tellez-Zenteno; Linda Huh; Edward Leung; Philippe Major
Journal:  Front Neurol       Date:  2019-07-03       Impact factor: 4.003

8.  Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats.

Authors:  Kelly A Deabold; Wayne S Schwark; Lisa Wolf; Joseph J Wakshlag
Journal:  Animals (Basel)       Date:  2019-10-19       Impact factor: 2.752

9.  Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs.

Authors:  Lauri-Jo Gamble; Jordyn M Boesch; Christopher W Frye; Wayne S Schwark; Sabine Mann; Lisa Wolfe; Holly Brown; Erin S Berthelsen; Joseph J Wakshlag
Journal:  Front Vet Sci       Date:  2018-07-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.